Commentary: The challenge of prevention in China

Int J Epidemiol. 2010 Feb;39(1):254-5. doi: 10.1093/ije/dyp381. Epub 2010 Jan 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents / economics*
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / prevention & control
  • China
  • Cost-Benefit Analysis
  • Humans
  • Hypertension / drug therapy*
  • Primary Prevention / economics
  • Risk Factors

Substances

  • Antihypertensive Agents